Asia Pacific Biotechnology Market (2008-2012)
| Publication Date | August 2008 |
|---|---|
| Publisher | RNCOS |
| Product Type | Report |
| Pages | 110 |
| ISBN Number | not applicable |
| Product Code | RCS00471 |
Summary
Key Findings
Growing at an estimated CAGR of 15.9% between 2005 and 2007, the value of Asia-Pacific Biotechnology market in 2007 was more than US$ 41 Billion. Japan, China, and Australia are the three largest biotechnology markets in the Asia-Pacific region, with combined market share of around 79% in 2007. The medical biotechnology sector presently accounts for the highest share in the overall market. Japan remains the largest biotech market in the region; therefore, the country represents a more mature market as compared to other neighboring markets. China and India, with low costs and big talent pool, are likely to emerge as the most potential biotech research and manufacturing outsourcing destinations in the future. Asia-Pacific is expected to become a major destination for stem cell research and biogeneric manufacturing.Key Issues and Facts
The research report addresses the issues and facts critical to success in the emerging biotechnology industry in Asia-Pacific:- What are the market trends in the Asia-Pacific Biotechnology industry?
- An insight into the biotechnology industries of Japan, China, India, South Korea, Australia, Taiwan, New Zealand and Singapore.
- An overview of Bioclusters in the Asia-Pacific Biotechnology industry.
- Key sectors in the Asia-Pacific Biotechnology industry.
- Course of market growth for the next 5 years.
- Opportunities that can be leveraged by the Asia-Pacific Biotechnology industry.
- Forces that are driving the biotechnology industry in the Asia-Pacific region.
- Challenges faced by the Asia-Pacific Biotechnology industry.
Research Methodology
Information Sources
Information has been sourced from various authentic and reliable sources like books, newspapers, trade journals & white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.Analysis Methods
The analysis methods comprise of Ratio Analysis, Historical Trend Analysis, Linear Regression Analysis (using software tools), Judgmental Forecasting, and Cause and Effect Analysis.Content
- 1. Analyst View
- 2. Global Biotechnology Industry Overview
- 2.1 Market Overview
- 2.1.1 Product Segmentation
- 2.1.2 Geographical Segmentation
- 2.1 Market Overview
- 3. Asia-Pacific Biotechnology Market
- 3.1 Market Overview
- 3.1.1 Product Segmentation
- 3.1.2 Geographical Segmentation
- 3.2 What Makes Asia-Pacific Biotech Market Capable?
- 3.2.1 Strong Government Support
- 3.2.2 Human Resources
- 3.2.3 Bio-diversity
- 3.2.4 Infrastructure
- 3.2.5 Low Cost
- 3.1 Market Overview
- 4. Asia-Pacific Biotechnology Market by Country
- 4.1 Japan
- 4.1.1 Market Overview
- 4.1.2 Product Segmentation
- 4.1.3 Bio-clusters
- 4.1.4 Success & Risk Factors
- 4.1.4.1 Success Factors
- 4.1.4.2 Risk Factors
- 4.1.5 Future Outlook (2008-2012)
- 4.2 China
- 4.2.1 Market Overview
- 4.2.2 Product Segmentation
- 4.2.3 Bio-clusters
- 4.2.4 Success & Risk Factors
- 4.2.4.1 Success Factors
- 4.2.4.2 Risk Factors
- 4.2.5 Future Outlook (2008-2012)
- 4.3 India
- 4.3.1 Market Overview
- 4.3.2 Product Segmentation
- 4.3.3 Bio-clusters
- 4.3.4 Success & Risk Factors
- 4.3.4.1 Success Factors
- 4.3.4.2 Risk Factors
- 4.3.5 Future Outlook (2008-09 to 2012-13)
- 4.4 Australia
- 4.4.1 Market Overview
- 4.4.2 Bio-clusters
- 4.4.3 Success & Risk Factors
- 4.4.3.1 Success Factors
- 4.4.3.2 Risk Factors
- 4.4.4 Future Outlook (2008-09 to 2012-13)
- 4.5 Taiwan
- 4.5.1 Market Overview
- 4.5.2 Bio-clusters
- 4.5.3 Success & Risk Factors
- 4.5.3.1 Success Factors
- 4.5.3.2 Risk Factors
- 4.5.4 Future Outlook (2008-2012)
- 4.6 South Korea
- 4.6.1 Market Overview
- 4.6.2 Product Segmentation
- 4.6.3 Bio-clusters
- 4.6.4 Success & Risk Factors
- 4.6.4.1 Success Factors
- 4.6.4.2 Risk Factors
- 4.6.5 Future Outlook (2008-2012)
- 4.7 New Zealand
- 4.7.1 Market Overview
- 4.7.2 Product Segmentation
- 4.7.3 Bio-clusters
- 4.7.4 Success & Risk Factors
- 4.7.4.1 Success Factors
- 4.7.4.2 Risk Factors
- 4.7.5 Future Outlook (2008-2012)
- 4.8 Singapore
- 4.8.1 Market Overview
- 4.8.2 Bio-clusters
- 4.8.3 Success & Risk Factors
- 4.8.3.1 Success Factors
- 4.8.3.2 Risk Factors
- 4.8.4 Future Outlook (2008-2012)
- 4.1 Japan
- 5. Emerging Sectors
- 5.1 Contract Research/Manufacturing
- 5.2 Vaccines
- 5.3 Generics
- 5.4 Stem Cell Research
- 5.5 Nanotechnology
- 5.6 Bioinformatics
- 6. Roadblocks
- 6.1 Lack of IPR Regime
- 6.2 Lack of Private Participation
- 6.3 Lack of Bioventures
- 6.4 Lack of Cash
- 7. Future Outlook
- 7.1 Increased Government Support
- 7.2 Role of Private Sector
- 7.3 Improved Intellectual Property Regime
- 7.4 Mergers & Acquisitions
- 7.5 Infrastructure Improvement
- 7.6 Sustained Growth in Revenues Through 2012
- 8. Competitive Landscape
- 8.1 Invitrogen Corporation
- 8.2 Takara Holdings, Inc.
- 8.3 CSL Limited
- 8.4 Biota Holdings Limited
- 8.5 GlaxoSmithKline Plc
- List of Figures:
- Figure 2-1: Global - Biotechnology Market (in Million US$), 2005-2007E
- Figure 2-2: Global - Forecast for Biotechnology Market (in Million US$), 2008-2012
- Figure 2-3: Global - Biotechnology Market by Segment (%), 2006
- Figure 2-4: Global - Biotechnology Market by Region (%), 2006
- Figure 3-1: Asia-Pacific* - Biotechnology Market (in Million US$), 2005-2007
- Figure 3-2: Asia-Pacific - Biotechnology Market by Segment (%), 2006
- Figure 3-3: Asia-Pacific - Biotechnology Market by Country (%), 2007
- Figure 4-1: Japan - Biotechnology Market (in Billion JPY), 1998-2007
- Figure 4-2: Japan - Biotechnology Market by Segment (in Billion JPY), 2005 & 2007
- Figure 4-3: Japan - Biotechnology Market by Segment (%), 2005 & 2007
- Figure 4-4: Japan - Medical & Healthcare Biotechnology Market by Segment (%), 2007
- Figure 4-5: Japan - Geographical Distribution of Bio-Clusters
- Figure 4-6: Japan - Forecast for Biotechnology Market (in Billion JPY), 2008-2012
- Figure 4-7: China - Biotechnology Market (in Billion Yuan), 2005-2007E
- Figure 4-8: China - Biotechnology Market by Segment (%), 2006
- Figure 4-9: China - Forecast for Biotechnology Market (in Billion Yuan), 2008-2012
- Figure 4-10: India - Investments in Biotechnology Market (in Million US$), 2001-02 to 2007-08
- Figure 4-11: India - Biotechnology Market (in Billion INR), 2002-03 to 2007-08E
- Figure 4-12: India - Exports & Domestic Consumption of Biotechnology Market (%), 2006-07
- Figure 4-13: India - Biotech Companies by Segment (%), 2006-07
- Figure 4-14: India - Biotechnology Market by Segment (%), 2007-08E
- Figure 4-15: India - Biopharmaceutical Market by Segment (%), 2006-07
- Figure 4-16: India - Forecast for Biotechnology Market (in Billion INR), 2008-09 to 2012-13
- Figure 4-17: India - Forecast for Biotechnology Market by Segment (%), 2012-13
- Figure 4-18: Australia - Biotechnology Market (in Billion AU$), 1998-99, 2002-03 to 2007-08E
- Figure 4-19: Australia - Geographical Distribution of Bio-clusters
- Figure 4-20: Australia - Forecast for Biotechnology Market (in Billion AU$), 2008-09 to 2012-13
- Figure 4-21: Taiwan - Investments in the Biotechnology Market (in Million US$), 2006 & 2007
- Figure 4-22: Taiwan - Biotechnology Market (in Million US$), 2003-2007E
- Figure 4-23: Taiwan - Forecast for Biotechnology Market (in Million US$), 2008-2012
- Figure 4-24: South Korea - Biotechnology Market (in Million US$), 2002-2007E
- Figure 4-25: South Korea - Biotechnology Market* by Segment (%), 2004
- Figure 4-26: South Korea - Geographical Distribution of Bio-clusters
- Figure 4-27: South Korea - Forecast for Biotechnology Market (in Million US$), 2008-2012
- Figure 4-28: New Zealand - Biotechnology Market* (in Million NZ$), 1999 & 2004-2007E
- Figure 4-29: New Zealand - Biotechnology Market* by Segment (%), 2005
- Figure 4-30: New Zealand - Geographical Distribution of Bio-clusters
- Figure 4-31: New Zealand - Forecast for Biotechnology Market (in Million NZ$), 2008-2012
- Figure 4-32: Singapore - Biotechnology Market* (in Million US$), 2005-2007
- Figure 4-33: Singapore - Forecast for Biotechnology Market (in Million US$), 2008-2012
- Figure 5-1: India - Contract Research Market (in Million US$), 2002, 2006, 2007E & 2012F
- Figure 5-2: India - Contract Manufacturing Market (in Millon US$), 2004, 2006, 2007E & 2012F
- Figure 5-3: Global - Nanotechnology Applications in Life Sciences (in Billion US$), 2005E & 2010F
- Figure 7-1: Asia-Pacific* - Forecast for Biotechnology Market (in Million US$), 2008-2012
- Figure 7-2: Asia-Pacific - Forecast for Biotechnology Market by Country (%), 2012
- List of Tables:
- Table 4-1: India - Top 20 Biotech Companies by Revenue (in Million INR), 2006-07
- Table 4-2: South Korea - Growth in Major Segments of Biotechnology Market (%), 1999-2004
About this Product
Delivery Details
PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)
PRINT/CD-ROM:Despatched within 2 to 4 working days.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















